OncoSec Medical Incorporated
ONCS
ONCS was delisted on the 23rd of June, 2023.
12 hedge funds and large institutions have $5.67M invested in OncoSec Medical Incorporated in 2015 Q2 according to their latest regulatory filings, with 12 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$5.23M |
| 2 |
Morgan Stanley
New York
|
+$310K |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$234K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$138K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$25.5K |
Top Sellers
ONCS Hedge Fund Activity: Q2 2015 in Review
12 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical Incorporated (ONCS) for Q2 2015, worth a combined $5.67M.
Buyers outnumbered sellers: 12 funds opened new ONCS positions and 0 closed out — a net gain of 12 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $5.23M.
- 12 institutional investors held OncoSec Medical Incorporated (ONCS) as of Q2 2015, up from 0 in Q1 2015.
- Funds reported $5.67M of OncoSec Medical Incorporated stock for Q2 2015.
- 12 funds opened new OncoSec Medical Incorporated positions in Q2 2015 and 0 closed out, a net change of +12 holders.
- The largest OncoSec Medical Incorporated buyer in Q2 2015 was Sabby Management, an estimated $5.23M added.
Based on aggregated 13F filings for Q2 2015.